New CEO for Cellaïon
The biotech company Cellaïon, based in the Walloon biotechnology valley in Mont-St-Guibert, Belgium, has appointed a new CEO: Dr James Neil Phillips has taken on the role, succeeding Cellaïon’s founder Etienne Sokal.
The new Cellaïon-CEO James Neil Phillips is a registered medical doctor and holds an MBA from Bayes Business School in London. With over 25 years’ experience in the pharmaceutical industry, he brings expertise in product development and commercialisation. He was previously CEO of Paion AG, Managing Director of Imevax GmbH and CEO of Midatech Pharma for five years. Philipps was CEO and founder of Talisker Pharma (founded in 2004 and later acquired by EUSA Pharma in 2006). He was also Chairman of Prosonix from 2007 to 2012. His career has also included senior positions at Johnson & Johnson and Novartis. In 2022, he founded the Sofiia Okunevska Foundation, which provides medical aid and relief supplies to Ukraine. Etienne Sokal will assume the role of Chairman of the Scientific and Medical Advisory Board and Vice Chairman of the Board of Directors.
The company is developing a cell therapy that utilises the anti-inflammatory and regenerative signalling properties of liver stem cells.
NOD-Proteindesign.Andreas Heddergott/TUM.jpg
Certest
Consilium